Eli Lilly Corp. buy BMO Capital Markets
Start price
14.01.26
/
50%
€916.70
Target price
14.01.27
-
Performance (%)
6.40%
Price
21:58
€975.40
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 6.40%. This prediction currently runs until 14.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -0.366% | -0.366% |
| iShares Core DAX® | 0.271% | 1.796% |
| iShares Nasdaq 100 | 1.884% | 2.153% |
| iShares Nikkei 225® | 3.579% | 5.306% |
| iShares S&P 500 | 0.151% | 1.090% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-21.39%
04.07.25
04.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
28.09%
08.02.25
08.02.25